» Articles » PMID: 16232557

Rhodobacter Sphaeroides Mutants Which Accumulate 5-aminolevulinic Acid Under Aerobic and Dark Conditions

Overview
Journal J Biosci Bioeng
Date 2005 Oct 20
PMID 16232557
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The photosynthetic bacterium Rhodobacter sphaeroides accumulates 5-aminolevulinic acid (ALA), which is a precursor in tetrapyrrole biosynthesis, under light illumination and upon addition of levulinic acid as an inhibitor of ALA dehydratase. To generate an industrial strain which produces ALA in the absence of light, we sequentially mutated R. sphaeroides CR-286 using N-methyl-N'-nitro-N-nitrosoguanidine (NTG). The mutant strains were screened by cultivating in the absence of light and assayed for ALA by the Ehrlich reaction in a 96-well microtiter plate. The mutant strain CR-386, derived from R. sphaeroides CR-286, was selected as a mutant that exhibited significant ALA accumulation. While CR-286 required light illumination for ALA production, CR-386 was able to accumulate 1.5 mM ALA in the presence of 50 mM glucose, 60 mM glycine, 15 mM levulinic acid and 1.0% (w/v) yeast extract under conditions of agitation in the absence of light. The mutant strain CR-450, derived from strain CR-386, was selected further as a mutant that exhibited significant ALA accumulation but no accumulation of aminoacetone, analogue of ALA. CR-450 accumulated 3.8 mM ALA under the same conditions. In the presence of 50 mM glucose, 60 mM glycine, 5 mM levulinic acid and 1.0% (w/v) yeast extract, the mutant strain CR-520, derived from strain CR-450, and strain CR-606, derived from strain CR-520, accumulated 8.1 mM and 11.2 mM ALA, respectively. In batch fermentation, the strain CR-606 accumulated 20 mM ALA over 18 h after the addition of glycine, levulinic acid, glucose and yeast extract.

Citing Articles

High-yield porphyrin production through metabolic engineering and biocatalysis.

Chen H, Wang Y, Wang W, Cao T, Zhang L, Wang Z Nat Biotechnol. 2024; .

PMID: 38839873 DOI: 10.1038/s41587-024-02267-3.


Systems metabolic engineering of Escherichia coli for hyper-production of 5‑aminolevulinic acid.

Pu W, Chen J, Zhou Y, Qiu H, Shi T, Zhou W Biotechnol Biofuels Bioprod. 2023; 16(1):31.

PMID: 36829220 PMC: 9951541. DOI: 10.1186/s13068-023-02280-9.


Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification.

Ye C, Yang Y, Chen X, Yang L, Hua X, Yang M J Biol Eng. 2022; 16(1):26.

PMID: 36229878 PMC: 9563957. DOI: 10.1186/s13036-022-00307-7.


Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5-aminolevulinic acid.

Chen J, Li X, Liu Y, Su T, Lin C, Shao L Microb Biotechnol. 2021; 14(5):2130-2139.

PMID: 34272828 PMC: 8449674. DOI: 10.1111/1751-7915.13894.


Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection.

Takano T, Satoh K, Doki T Front Vet Sci. 2021; 8:647189.

PMID: 33644160 PMC: 7903937. DOI: 10.3389/fvets.2021.647189.